http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108126136-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33f8d7fa4fff9e0cbbab70bf2ed14c76
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8905
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-902
filingDate 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3db091b05b96093bb195937a4d12cdba
publicationDate 2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108126136-A
titleOfInvention A kind of capsule medicine and preparation method for treating chronic pelvic inflammatory disease
abstract The invention belongs to field of traditional Chinese, it is therefore an objective to provide a kind of capsule medicine for treating chronic pelvic inflammatory disease according to the understanding mechanism of Chinese traditional treatment chronic pelvic inflammatory disease, each component and its mass parts ratio of the drug are as follows:30~100g of pangolin, 100~260g of honeysuckle, 30~100g of radix scutellariae, melon wither 100~160g, 100~350g of dandelion, 150~350g of Chinese violet, 150~300g of Fructus Forsythiae, 30~120g of spina gleditsiae, 60~150g of the radix paeoniae rubrathe, 80~180g of Radix Angelicae Sinensis, 100~160g of Caulis Spatholobi, 50~120g of trigone, 60~100g of moutan bark, 50~120g of Rhizoma Chuanxiong, rhizoma cyperi(Vinegar system)50~120g, 80~160g of peach kernel, 80~160g of corydalis tuber, 80~160g of the seed of cowherb, 60~160g of field pennycress, 100~160g of Sargent gloryvine;Drug provided by the invention is a good Chinese prescription.
priorityDate 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758

Total number of triples: 39.